Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (231)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by SCHONBERGER, L. B.
Right arrow Articles by BRYAN, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHONBERGER, L. B.
Right arrow Articles by BRYAN, J. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

American Journal of Epidemiology Vol. 110, No. 2: 105-123
Copyright © 1979 by The Johns Hopkins University School of Hygiene and Public Health


research-article

GUILLAIN-BARRE SYNDROME FOLLOWING VACCINATION IN THE NATIONAL INFLUENZA IMMUNIZATION PROGRAM, UNITED STATES, 1976–19771

LAWRENCE B. SCHONBERGER, DENNIS J. BREGMAN, JOHN Z SULLIVAN-BOLYAI, RICHARD A. KEENLYSIDE, DONALD W. ZIEGLER, HENRY F. RETAILLIAU, DONALD L EDDINS and JOHN A. BRYAN

Reprint requests to Dr Schonberger

Because of an increase in the number of reports of Guillain-Barre syndrome (GBS) following A/New Jersey influenza vaccination, the National Influenza Immunization Program was suspended December 16, 1976 and nationwide surveillance for GBS was begun. This surveillance uncovered a total of 1098 patients with onset of GBS from October 1, 1976, to January 31, 1977, from all 50 states, District of Columbia, and Puerto Rico. A total of 532 patients had recently received an A/New Jersey influenza vaccination prior to their onset of GBS (vaccinated cases), and 15 patients received a vaccination after their onset of GBS. Five hundred forty-three patients had not been recently vaccinated with A/New Jersey influenza vaccine and the vaccination status for 8 was unknown. Epidemiologic evidence indicated that many cases of GBS were related to vaccination. When compared to the unvaccinated population, the vaccinated population had a significantly elevated attack rate in every adult age group. The estimated attributable risk of vaccine-related GBS in the adult population was just under one case per 100,000 vaccinations. The period of increased risk was concentrated primarily within the 5-week period after vaccination, although it lasted for approximately 9 or 10 weeks.

Guillain-Barre syndrome; Immunization; Influenza; polyradiculitis; vaccination; vaccine


1 From the Viral Diseases Division, Bureau of Epidemiology, Center for Disease Control, Atlanta, GA 30333.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
LupusHome page
N. Agmon-Levin, S. Kivity, M. Szyper-Kravitz, and Y. Shoenfeld
Transverse myelitis and vaccines: a multi-analysis
Lupus, November 1, 2009; 18(13): 1198 - 1204.
[Abstract] [PDF]


Home page
LupusHome page
H. Orbach and A. Tanay
Vaccines as a trigger for myopathies
Lupus, November 1, 2009; 18(13): 1213 - 1216.
[Abstract] [PDF]


Home page
BMJHome page
L. C. Price
Should I have an H1N1 flu vaccination after Guillain-Barre syndrome?
BMJ, September 9, 2009; 339(sep09_1): b3577 - b3577.
[Full Text]


Home page
JAMAHome page
B. A. Slade, L. Leidel, C. Vellozzi, E. J. Woo, W. Hua, A. Sutherland, H. S. Izurieta, R. Ball, N. Miller, M. M. Braun, et al.
Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine
JAMA, August 19, 2009; 302(7): 750 - 757.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. B. Belshe
Implications of the Emergence of a Novel H1 Influenza Virus
N. Engl. J. Med., June 18, 2009; 360(25): 2667 - 2668.
[Full Text] [PDF]


Home page
Am J EpidemiolHome page
J. Stowe, N. Andrews, L. Wise, and E. Miller
Investigation of the Temporal Association of Guillain-Barre Syndrome With Influenza Vaccine and Influenzalike Illness Using the United Kingdom General Practice Research Database
Am. J. Epidemiol., February 1, 2009; 169(3): 382 - 388.
[Abstract] [Full Text] [PDF]


Home page
Complementary Health Practice ReviewHome page
L. F. Vernon and C. Kent
Chiropractors and Vaccinations: Ethics is the Real Issue
Complementary Health Practice Review, January 1, 2009; 14(1): 36 - 50.
[Abstract] [PDF]


Home page
PediatricsHome page
Committee on Infectious Diseases
Prevention of Influenza: Recommendations for Influenza Immunization of Children, 2007-2008
Pediatrics, April 1, 2008; 121(4): e1016 - e1031.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
M. F. Daley, L. A. Crane, V. Chandramouli, B. L. Beaty, J. Barrow, N. Allred, S. Berman, and A. Kempe
Misperceptions About Influenza Vaccination Among Parents of Healthy Young Children
Clinical Pediatrics, June 1, 2007; 46(5): 408 - 417.
[Abstract] [PDF]


Home page
Epidemiol RevHome page
J. D. Grabenstein, P. R. Pittman, J. T. Greenwood, and R. J.M. Engler
Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects
Epidemiol. Rev., August 1, 2006; 28(1): 3 - 26.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. A. Hughes, J. Charlton, R. Latinovic, and M. C. Gulliford
No association between immunization and guillain-barre syndrome in the United kingdom, 1992 to 2000.
Arch Intern Med, June 26, 2006; 166(12): 1301 - 1304.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. W. McMahon, J. Iskander, P. Haber, S. Chang, E. J. Woo, M. M. Braun, and R. Ball
Adverse Events After Inactivated Influenza Vaccination Among Children Less Than 2 Years of Age: Analysis of Reports From the Vaccine Adverse Event Reporting System, 1990-2003
Pediatrics, February 1, 2005; 115(2): 453 - 460.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
P. Haber, F. DeStefano, F. J. Angulo, J. Iskander, S. V. Shadomy, E. Weintraub, and R. T. Chen
Guillain-Barre Syndrome Following Influenza Vaccination
JAMA, November 24, 2004; 292(20): 2478 - 2481.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Madjid, M. Naghavi, S. Litovsky, and S. W. Casscells
Influenza and Cardiovascular Disease: A New Opportunity for Prevention and the Need for Further Studies
Circulation, December 2, 2003; 108(22): 2730 - 2736.
[Full Text] [PDF]


Home page
PediatricsHome page
M. B. Rennels, H. C. Meissner, and Committee on Infectious Diseases
Technical Report: Reduction of the Influenza Burden in Children
Pediatrics, December 1, 2002; 110(6): e80 - e80.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
F. Ahmed, J. A. Singleton, and A. L. Franks
Influenza Vaccination for Healthy Young Adults
N. Engl. J. Med., November 22, 2001; 345(21): 1543 - 1547.
[Full Text] [PDF]


Home page
NEJMHome page
R. B. Couch
Prevention and Treatment of Influenza
N. Engl. J. Med., December 14, 2000; 343(24): 1778 - 1787.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
U. Seneviratne
Guillain-Barre syndrome
Postgrad. Med. J., December 1, 2000; 76(902): 774 - 782.
[Abstract] [Full Text]


Home page
NeurologyHome page
R. Van Koningsveld, P. A. Van Doorn, P. I. M. Schmitz, C. W. Ang, and F. G. A. Van der Meche
Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the Netherlands
Neurology, February 8, 2000; 54(3): 620 - 620.
[Abstract] [Full Text] [PDF]


Home page
Eval RevHome page
D. A. Freedman and P. B. Stark
The Swine Flu Vaccine and Guillain-BarrE Syndrome: A Case Study in Relative Risk and Specific Causation
Eval Rev, December 1, 1999; 23(6): 619 - 647.
[Abstract] [PDF]


Home page
NEJMHome page
T. Lasky, G. J. Terracciano, L. Magder, C. L. Koski, M. Ballesteros, D. Nash, S. Clark, P. Haber, P. D. Stolley, L. B. Schonberger, et al.
The Guillain-Barre Syndrome and the 1992-1993 and 1993-1994 Influenza Vaccines
N. Engl. J. Med., December 17, 1998; 339(25): 1797 - 1802.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. T. Chen, J. W. Glasser, P. H. Rhodes, R. L. Davis, W. E. Barlow, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, C. M. Vadheim, et al.
Vaccine Safety Datalink Project: A New Tool for Improving Vaccine Safety Monitoring in the United States
Pediatrics, June 1, 1997; 99(6): 765 - 773.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
N. Fiebach and W. Beckett
Prevention of Respiratory Infections in Adults: Influenza and Pneumococcal Vaccines
Arch Intern Med, November 28, 1994; 154(22): 2545 - 2557.
[Abstract] [PDF]


Home page
NEJMHome page
P. Gardner and W. Schaffner
Immunization of Adults
N. Engl. J. Med., April 29, 1993; 328(17): 1252 - 1258.
[Full Text]


Home page
Arch NeurolHome page
E. C. Alvord Jr
Swine Influenza Vaccine and Guillain-Barre Syndrome: Lies, Damn Lies, and...
Arch Neurol, October 1, 1986; 43(10): 979 - 979.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. T. Kurland and W. C. Wiederholt
Swine Influenza Vaccine and Guillain-Barre Syndrome: Lies, Damn Lies, and...-Reply
Arch Neurol, October 1, 1986; 43(10): 979 - 981.
[Abstract] [PDF]


Home page
Arch NeurolHome page
E. Beghi, L. T. Kurland, D. W. Mulder, and W. C. Wiederholt
Guillain-Barre Syndrome: Clinicoepidemiologic Features and Effect of Influenza Vaccine
Arch Neurol, November 1, 1985; 42(11): 1053 - 1057.
[Abstract] [PDF]


Home page
Arch NeurolHome page
L. T. Kurland, W. C. Wiederholt, J. W. Kirkpatrick, and H. G. Potter
Swine Influenza Vaccine and Guillain-Barre Syndrome: Epidemic or Artifact?
Arch Neurol, November 1, 1985; 42(11): 1089 - 1090.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. M. Poser
Swine Influenza Vaccination: Truth and Consequences
Arch Neurol, November 1, 1985; 42(11): 1090 - 1092.
[Abstract] [PDF]


Home page
ScienceHome page
U Jahnke, E. Fischer, and E. Alvord Jr
Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis
Science, July 19, 1985; 229(4710): 282 - 284.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Prevention and Control of Influenza: Recommendation of the Immunization Practices Advisory Committee
Ann Intern Med, August 1, 1984; 101(2): 218 - 222.
[Abstract] [PDF]


Home page
JAMAHome page
L. T. Kurland, C. A. Molgaard, E. M. Kurland, W. C. Wiederholt, and J. W. Kirkpatrick
Swine Flu Vaccine and Multiple Sclerosis
JAMA, May 25, 1984; 251(20): 2672 - 2675.
[Abstract] [PDF]


Home page
JAMAHome page
J. E. Kaplan, J. R. Greenspan, M. Bomgaars, N. Wiebenga, R. D. Bart Jr, K. Robbins, R. Wiebe, F. Tabrah, J. Stewart, and L. B. Schonberger
Simultaneous Outbreaks of Guillain-Barre Syndrome and Bell's Palsy in Hawaii in 1981
JAMA, November 18, 1983; 250(19): 2635 - 2640.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Influenza Vaccines 1983-1984: Recommendation of the Immunization Practices Advisory Committee
Ann Intern Med, October 1, 1983; 99(4): 497 - 499.
[Abstract] [PDF]


Home page
JAMAHome page
M. A. Riddiough, J. E. Sisk, and J. C. Bell
Influenza Vaccination: Cost-effectiveness and Public Policy
JAMA, June 17, 1983; 249(23): 3189 - 3195.
[Abstract] [PDF]


Home page
JAMAHome page
K. V. Eden
Possible Association of Guillain-Barre Syndrome With Thrombolytic Therapy
JAMA, April 15, 1983; 249(15): 2020 - 2021.
[Abstract] [PDF]


Home page
JAMAHome page
S. B. Thacker, K. Choi, and P. S. Brachman
The Surveillance of Infectious Diseases
JAMA, March 4, 1983; 249(9): 1181 - 1185.
[Abstract] [PDF]


Home page
JAMAHome page
K. W. Bernard, P. W. Smith, F. J. Kader, and M. J. Moran
Neuroparalytic Illness and Human Diploid Cell Rabies Vaccine
JAMA, December 17, 1982; 248(23): 3136 - 3138.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Influenza Vaccines 1982-1983: Recommendation of the Immunization Practices Advisory Committee
Ann Intern Med, October 1, 1982; 97(4): 581 - 583.
[Abstract] [PDF]


Home page
JAMAHome page
J. E. Kaplan, P. Katona, E. S. Hurwitz, and L. B. Schonberger
Guillain-Barre Syndrome in the United States, 1979-1980 and 1980-1981: Lack of an Association With Influenza Vaccination
JAMA, August 13, 1982; 248(6): 698 - 700.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. T. OSTERHOLM and J. C. FORFANG
Surveillance of Toxic Shock Syndrome in Minnesota: Comments on National Surveillance
Ann Intern Med, June 1, 1982; 96(6_Part_2): 887 - 890.
[Abstract] [PDF]


Home page
JAMAHome page
S. W. Brostoff and T. M. White
Absence of P2 Protein in Swine Flu Vaccines
JAMA, January 22, 1982; 247(4): 495 - 495.
[Abstract] [PDF]


Home page
Arch NeurolHome page
D. E. Johnson
Guillain-Barre Syndrome in the US Army
Arch Neurol, January 1, 1982; 39(1): 21 - 24.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Influenza Vaccine 1981-1982: Recommendations of the Public Health Service Immunization Practices Advisory Committee
Ann Intern Med, October 1, 1981; 95(4): 461 - 463.
[Abstract] [PDF]


Home page
JAMAHome page
G. L. Lattimer
Legionnaires' Disease Legacies
JAMA, November 28, 1980; 244(21): 2416 - 2416.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
Influenza Vaccine 1980-1981: Recommendation of the Public Health Service Immunization Practices Advisory Committee
Ann Intern Med, September 1, 1980; 93(3): 466 - 468.
[Abstract] [PDF]


Home page
ScienceHome page
L Gordis and E Gold
Privacy, confidentiality, and the use of medical records in research
Science, January 11, 1980; 207(4427): 153 - 156.
[PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.